Amplitude-integrated electroencephalography shows that doxapram influences the brain activity of preterm infants

Acta Paediatrica, International Journal of Paediatrics

Volumn 103, Issue 9, 2014, Pages 922-927

  Czaba Hnizdo, Christine ^a   Olischar, Monika ^a   Rona, Zsofia ^a   Weninger, Manfred ^a   Berger, Angelika ^a   Klebermass Schrehof, Katrin ^a  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

Author keywords

Amplitude integrated electroencephalography; Brain activity; Doxapram; Preterm infant; Seizure activity

Indexed keywords

CAFFEINE CITRATE; DOXAPRAM; STEROID; RESPIRATORY TRACT AGENT;

AMPLITUDE INTEGRATED ELECTROENCEPHALOGRAPHY; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE ACTIVITY; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; LOADING DRUG DOSE; MALE; NEWBORN; NEWBORN APNEA; PRIORITY JOURNAL; SEIZURE; SLEEP WAKING CYCLE; STEROID THERAPY; UNSPECIFIED SIDE EFFECT; APNEA; BRAIN; DRUG EFFECTS; INFANT, PREMATURE, DISEASES; PHYSIOLOGY; PREMATURITY; PROCEDURES; RETROSPECTIVE STUDY;

APNEA; BRAIN; DOXAPRAM; ELECTROENCEPHALOGRAPHY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; RESPIRATORY SYSTEM AGENTS; RETROSPECTIVE STUDIES;

EID: 84906673396     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12681     Document Type: Article

References (27)

1. Roll C, Horsch S,. Effect of doxapram on cerebral blood flow velocity in preterm infants. Neuropediatrics 2004; 35: 126-9.
2. Schmid B,. Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway? J Pediatr 1999; 135: 52-528.
3. Martin RJ, Fanaroff AA,. Neonatal apnea, bradycardia, or desaturation: does it matter? J Pediatr 1998; 132: 758-9.
4. Barrington KJ, Finer NN, Torok-Both G, Jamali F, Coutts RT,. Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity. Pediatrics 1987; 80: 22-7.
5. Henderson-Smart DJ, Steer PA,. Doxapram treatment for apnea in preterm infants. Cochrane Database Syst Rev 2001; (4): CD000074.
6. Fischer C, Ferdynus C, Gouyon JB, Semama DS,. Doxapram and hypokalaemia in very preterm infants. Arch Dis Child Fetal Neonatal Ed 2013; 98: F416-8.
7. Barrington KJ, Finer NN, Peters KL, Barton J,. Physiological effects of doxapram in idiopathic apnea of prematurity. J Pediatr 1986; 108: 125-9.
8. Eyal F, Alpan G, Sagi E, Glick B, Peleg O, Dgani Y,. Aminophylline versus doxapram in idiopathic apnea of prematurity: a double-blind controlled study. Pediatrics 1985; 75: 709-13.
9. Bhatia J,. Current options in the management of apnea of prematurity. Clin Pediatr (Phila) 2000; 39: 327-36.
10. Mitchel RA, Herbert DA,. Potencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats. Anesthesiology 1975; 42: 559-66.
11. Cotton JF, Keshavaprasad B, Laster MJ,. The ventilator stimulant doxapram inhibits TASK tandem pore (K2P) potassium channel function but does not affect minimum alveolar anesthetic concentration. Anesth Analg 2006; 102: 779-85.
12. Hoecker C, Nelle M, Poeschl J, Beedgen B, Linderkamp O,. Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. Pediatrics 2002; 109: 784-7.
13. Pryds O, Schneider S,. Aminophylline reduces cerebral blood flow in stable, preterm infants without affecting the visual evoked potential. Eur J Pediatr 1991; 150: 366-9.
14. Tay-Uyboco J, Kwiatkowski K, Cates DB, Seifert B, Hasan SU, Rigatto H,. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity. Biol Neonate 1991; 59: 190-200.
15. Dear PR, Wheeler D,. Doxapram and neonatal apnoea. Arch Dis Child 1984; 59: 903-4.
16. Maillard C, Boutroy MJ, Fresson J, Barbé F, Hascoet JM,. QT interval lengthening in premature infants treated with doxapram. Clin Pharmacol Ther 2001; 70: 540-5.
17. Miletich DJ, Ivankovich AD, Albrecht RF, Bonnet RF, Reimann CR,. The effects of doxapram on cerebral blood flow and peripheral hemodynamics in the anesthetized and unanesthetizedgoat. Anesth Analg 1976; 55: 279-85.
18. Sreenan C, Etches PC, Demianczuk N, Robertson CMT,. Isolated mental developmental delay in low birth weight infants: association with prolonged doxapram therapy for apnea. J Pediatr 2001; 139: 832-7.
19. Dani C, Bertini G, Pezzati M, Pratesi S, Filippi L, Tronchin M, et al. Brain hemodynamic effects of doxapram in preterm infants. Biol Neonate 2006; 89: 69-74.
20. Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012; 307: 275-82.
21. Maynard D, Prior PF, Scott DF,. Device for continuous monitoring of cerebral activity in resuscitated patients. Br Med J 1969; 4: 545-6.
22. Hellstroem-Westas L, Rosen I, de Vries LS,. Amplitude-integrated EEG classification and interpretation in preterm and term infants. Neoreviews 2006; 2: 76-87.
23. Volpe JJ,. Neurology of the newborn. 4th ed. Philadelphia: WB Saunders, 2001.
24. de Vries LS, Eken P, Dubowitz LM,. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 1992; 49: 1-6.
25. Henderson-Smart DJ, Speer PA,. Doxapram treatment for apnea in preterm infants. Cochrane Database Syst Rev 2004; (4): CD000074.
26. Lando A, Klamer A, Jonsbo F, Weiss J, Greisen G,. Doxapram and developmental delay at 12 months in children born extremely preterm. Acta Paediatr 2005; 94: 1680-3.
27. Anderson-Beck R, Wilson L, Brazier S, Hughes IE, Peers C,. Doxapram stimulates dopamine release from the intact rat carotid body in vitro. Neurosci Lett 1995; 187: 25-8.